Skip to main content

Table 2 Patients’ Characteristics

From: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series

Case Age PS MIB-1 index IDH1 Mutation MGMT Methylation CGH Surgical removal Radiation TMZ cycles Other treatment
1 75 1 40.1 wild + 7p15.2-qter, − 10, −15q, (−16qcen-13) GTR 40Gy/15fr 22
2 39 1 11.1 wild + +1pter-34.1, −9pter-21, − 10q21.1-ter, +13q12.2–31, +17p12-q21.1, −18q23, −21q, +22qcen-13.1 GTR 60Gy/30fr 31 BCNU wafer
3 52 0 30 wild -1pter-36.1, + 7, −9pter-21, − 10 GTR 60Gy/30fr 14 BCNU wafer
4 50 0 50 wild + + 7, − 10, +12q15, +13q14.3–33 GTR 60Gy/30fr 14
  1. BCNU bis-chloroethylnitrosourea, CGH comparative genomic hybridization, GTR gross total resection, IDH isocitrate dehydrogenase, MGMT O6 methylguanine DNA methyltransferase, PS performance status, TMZ temozolomide